None of that diligence touches the actual risk, because the actual risk is upstream of the syringe, in a supply chain that cannot produce a verifiable vial no matter how carefully the end user handles it
Some clinicians overlap the medications briefly during the transition, continuing phentermine while semaglutide titrates up, then discontinuing phentermine once semaglutide reaches therapeutic levels
By imitating these hormones, it helps increase insulin production and lower blood sugar levels
But theres another side effect that isnt talked about as much in the official guidance, yet is filling Reddit threads with hundreds of comments: injection site reactions
This can lead to improved texture, reduced inflammation, and a healthy glow thats hard to achieve with topical treatments alone
Common adverse effects included gastrointestinal symptoms such as nausea and vomiting